Infographics

TB Laboratory Strengthening:

The Annual Tuberculosis (TB) Laboratory Project workshop with National TB Reference Laboratory managers from 23 countries in West and Central Africa, 11-13 December 2023. The main objective was to take stock of activities carried out within the framework of the TB Laboratory project.

Cameroon kicks off malaria vaccine rollout

Yaoundé – Cameroon today launched the RTS,S malaria vaccine into its routine national immunization services, becoming the first country to do so outside the malaria vaccine pilot programme that was carried out in Ghana, Kenya and Malawi. The introduction comes as efforts gather pace to scale up vaccination against the disease in high risk areas in Africa.

Bold Initiative to Combat Workplace Harassment and Sexual Exploitation and Abuse in ...

The Ethiopian country office of the World Health Organization (WHO Ethiopia) has taken a significant step towards addressing workplace harassment and sexual exploitation and abuse (SEA) in the health sector. 

In line with this, WHO Ethiopia successfully conducted three sessions of Training of Trainers (ToT) on National Health Sector Prevention and Response to Workplace Harassment and Sexual Exploitation and Abuse (NHS-PRWPH & SEA) guidelines.

Mauritius tackles anti-microbial resistance through formulation of a second Plan of ...

Mauritius has successfully developed its second national action plan on anti-microbial resistance (AMR) 2024-2028, through a three-week robust workshop supported by the World Health Organization. This comes following the evaluation of the first national action plan (NAP) 2018-2022 by the same team from the World Health Organization (WHO) and the Ministry of Health and Wellness (MOHW) in September 2023. The Ministry of Health and Wellness of Mauritius has shown great concern about the burden of AMR.  A significant number of deaths in Mauritius can be attributed to hospital-acquired infections, many of which are caused by drug-resistant organisms. The global findings are also worrying with 1.27 million deaths caused by AMR while a further 4.95 million deaths are associated with AMR in 2019. The WHO Representative Dr Anne Ancia has underlined the high rates of multi-drug organisms reported at hospital level and most importantly in the intensive care units. The growing rates of AMR and the decline in new antibiotics emerging on the pharmaceutical market are likely to accentuate the problem of lack of treatment for resistant infections contributing to higher mortality rates.